Key statistics
On Monday, Context Therapeutics Inc (6K9:FRA) closed at 1.85, -13.55% below its 52-week high of 2.14, set on Jan 29, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 1.85 |
|---|---|
| High | 1.85 |
| Low | 1.85 |
| Bid | 1.94 |
| Offer | 1.99 |
| Previous close | 1.88 |
| Average volume | 511.14 |
|---|---|
| Shares outstanding | 91.88m |
| Free float | 90.79m |
| P/E (TTM) | -- |
| Market cap | 206.73m USD |
| EPS (TTM) | -0.2835 USD |
Data delayed at least 15 minutes, as of Mar 02 2026 07:20 GMT.
More ▼
Announcements
- Context Therapeutics to Participate in Upcoming Investor Conferences
- Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Context Therapeutics Highlights CT-95 and CT-202 Programs at 2025 SITC Annual Meeting
- Context Therapeutics Reports Third Quarter 2025 Operating and Financial Results
- Context Therapeutics to Participate in Upcoming Investor Conferences
- Context Therapeutics Announces Poster Presentations at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting
- Context Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- Context Therapeutics to Participate in Upcoming Investor Conferences
- Context Therapeutics Reports Second Quarter 2025 Operating and Financial Results
- Context Therapeutics Announces CTIM-76 Trial in Progress Poster Presentation at 2025 ASCO Meeting
More ▼
